MedTech Acquisition - Warrants (18/12/2025) EBIT

MedTech Acquisition - Warrants (18/12/2025) (MTACW) currently reports a EBIT of $-29M as of June 2026. That compares with $-32M in the prior-year period — up 10.7% year over year. That is above the sector sector average of $-63M. Use the charts on this page to explore MedTech Acquisition - Warrants (18/12/2025)'s EBIT history and peer comparisons.

MedTech Acquisition - Warrants (18/12/2025)'s EBIT increased from $-32M to $-29M — a 10.7% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

MedTech Acquisition - Warrants (18/12/2025)'s EBIT of $-29M is higher than the its sector sector average of $-63M. That is roughly 54.4% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

MedTech Acquisition - Warrants (18/12/2025) reported $-29M in EBIT as of June 2026. That compares with $-32M in the prior-year period — up 10.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-29M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $-63M. From there, open related valuation or income-statement pages for MedTech Acquisition - Warrants (18/12/2025), and consider following MTACW for alerts when major investors trade the stock.